The beneficial actions of IL-1 disruption in post-infarction remodeling may be mediated through attenuation of pro-inflammatory signaling, or through loss of direct IL-1-mediated actions on matrix metabolism and on function of cardiac fibroblasts. The gene discussed is IL1A; the disease is infarction.